Ergoteles’s CONMED CNMD Stock Holding History

Ergoteles’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-21,143	Closed	-$1.87M	–	1334
2022 Q4	$1.87M	Buy	+21,143	New	+$1.75M	0.07%	297
2020 Q4	–	Sell	-3,400	Closed	-$267K	–	712
2020 Q3	$267K	Buy	+3,400	New	+$277K	0.04%	385

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Ergoteles's CNMD Position: Q1 2023 in Review

Ergoteles sold out of CONMED (CNMD) in Q1 2023, closing a stake of 21,143 shares — an estimated $1.87M sold.

Ergoteles first reported a position in CNMD in Q3 2020 and held it in 2 quarters. The position peaked at $1.87M in Q4 2022. 233 funds tracked by Wall St. Rank hold CNMD as of Q1 2023.

Ergoteles reported no remaining CONMED position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 21,143 CONMED shares in Q1 2023, an estimated $1.87M.
Ergoteles first reported a position in CONMED in Q3 2020 and held it in 2 quarters.
Ergoteles's CONMED position peaked at $1.87M in Q4 2022.
233 funds tracked by Wall St. Rank held CONMED as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.